Surveillance for antimicrobial resistance in Australian isolates of<i>Clostridium difficile</i>, 2013–14

Abstract

These data confirm the potent in vitro activity of fidaxomicin against C. difficile. Moreover, this study provides an important baseline for ongoing long-term surveillance of antimicrobial resistance and prospective tracking of prominent and emerging strain types.